Overview About Aplus Consultant

Challenge: The client, a European pharmaceutical company specializing in supportive cancer therapies, has a product (Product X) that may be approved for anti-emetic use in China in 2-3 years. They need to understand the current landscape of the anti-emetic drug market in China, how it may evolve, and assess the commercial opportunities for Product X. The objectives are to: 1) Explore the current and future anti-emetic drug market in China; 2) Evaluate the commercial opportunities for Product X and define the optimal pricing strategy; 3) Forecast Product X’s sales revenue over a 10-year period under three scenarios (worst, base, and best case). Solution: We conducted desktop research and IMS data analysis to provide a preliminary market outlook and establish key hypotheses, as well as created a discussion guide. We calculated patient flow and conducted comparative studies to analyze sales and price trends, laying the groundwork for a sales forecasting model. We interviewed key opinion leaders (KOLs) and conducted competitive intelligence (CI) interviews to understand pricing, entry barriers, and product positioning in the treatment landscape. Finally, we summarized key insights to deliver a high-level market strategy and designed a net present value (NPV) model for potential collaboration. Outcome: Our model estimated the commercial value of Product X to be 200% higher than the client’s original assumption. This allowed the client to segment the market by different metrics (postoperative nausea and vomiting, and chemotherapy-induced nausea and vomiting), identify key factors for hospital listing, and compile a list of potential Chinese partners for collaboration.

Challenge: The client is a leading pharmaceutical company in China, with steadily growing sales revenue in recent years but lacking core competitiveness. They aim to create more value from their existing sales channels, expand into overseas markets, and maximize the value of their premium products. The client is looking to acquire a U.S. company to produce high-quality health supplements and promote their products internationally. However, they lack a clear estimate of the growth potential and value of the target overseas market and have limited experience negotiating with business and trade partners. Solution: We analyzed epidemiological data, clinical practices, market trends, product pricing, and market share to forecast the product’s sales performance in overseas markets. By referencing the pricing of similar products in the target market, we assessed price sensitivity to provide an initial pricing recommendation for the local market entry and forecast price changes over the next few years. Through an evaluation of projected sales performance, clinical and marketing costs, we estimated the product’s value range between 1,500K to 5,000K USD and proposed a suitable business structure. Outcome: Considering the value of the client’s product, we provided a list of potential partners within the U.S. health supplement industry for collaboration on the client’s production line. The negotiation evidence and communication channels we supplied enabled the client to successfully engage in discussions with U.S. companies. The target product is expected to enrich the client’s product line and help expand their business in the U.S. market, generating an estimated $1 million in revenue within three years.

Challenge: The client is an innovative pharmaceutical company from Taiwan that is developing a transdermal patch for the treatment of Alzheimer’s disease, with plans to launch the product in the U.S. market within the next five years. However, due to a lack of knowledge about the U.S. market and legal requirements, the client is uncertain about how to enter the market. Additionally, the client seeks to better understand the product’s market value to gain a stronger negotiating position in future partnerships. Solution: We conducted market and sales research to identify market opportunities and developed an interview schedule. Through preliminary research and interviews with relevant stakeholders, we clarified the pricing strategy and identified entry barriers while analyzing similar therapies to understand the product’s market positioning. We then summarized the findings from both the initial and secondary research, determining the product’s value and market positioning, and created a net present value (NPV) model for the product, which included the best-case, worst-case, and normal-case scenarios. Outcome: Our client gained a clear understanding of the product’s commercial value. With our assistance, they established an NPV model and estimated the market value to be approximately $3 million. As a result, the client decided to select us as their consulting advisor and negotiated a partnership agreement.